Last updated on February 2018

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer

Brief description of study

The purpose of this study is to evaluate the serum testosterone levels in patients with Metastatic Castration-Resistant Prostate Cancer on SoluMatrix Abiraterone Acetate as Compared to Abiraterone Acetate

Detailed Study Description

This is 12-week, open-label study of abiraterone acetate in at least 50 patients with metastatic castration-resistant prostate cancer. The primary endpoint is total testosterone at pharmacokinetic steady-state. Additional secondary endpoints include safety assessments, PSA and pharmacokinetic measurements

Clinical Study Identifier: NCT02737332

Find a site near you

Start Over

Manatee Medical Research

Brandenton, FL United States
  Connect »